Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
University of Birmingham partners with Inteliphage to combat antibiotic-resistant infections.
Sep 17, 2026
Contract Type
partnership
BirminghamBiotechnologyHealth CareTherapeutics
Description
A new partnership between the Precision Health Technologies Accelerator (PHTA) at the University of Birmingham and Inteliphage aims to tackle the global health challenge of antibiotic-resistant infections. The collaboration focuses on developing personalized phage therapy as an effective treatment for infections that no longer respond to antibiotics.
Company Information
Company
Inteliphage
Location
Birmingham, England, United Kingdom
About
Inteliphage is a Belgium-headquartered company focused on bacteriophage technology. They are developing an integrated platform for personalized phage therapy. Their goal is to create innovative solutions for treating infections that are resistant to antibiotics.
Predictive Intelligence
Strategic
ML-powered predictions for Inteliphage's next move